KMR Group Clinical Data Surges In 2017

Published: Oct 12, 2017

CHICAGO, Illinois, October 11, 2017 – KMR Group, a leader in analyzing R&D performance data for the biopharmaceutical industry, recently completed its industry upload of proprietary clinical trial performance data consisting of nearly 30,000 trials and over 650,000 site records. The data is used by leading biopharma organizations to facilitate benchmarking and assess clinical strategy.

As biopharmaceutical companies and CROs consistently aim to reduce timelines while efficiently managing resources, using KMR Group’s data can provide executives with the necessary insights to improve clinical trial performance.

KMR Group’s expertise and understanding of clinical operations enables them to better deliver data back in a meaningful way, whether through online applications or consulting reports.

All the underlying data is provided directly to KMR Group from sponsor and CRO clients. Each data submission is extensively scrutinized and queried. Using their decades of experience working with clients, KMR runs hundreds of cross checks and works with companies to verify, review conflicts, and fill-in missing information during the submission process.

Companies seeking to evaluate their performance and gain insight have become reliant on this thorough review process which ensures they are being compared reliably to other companies with a consistent set of definitions.

The recent upload is remarkable for the increase in trials and site instances. Fueled by client expansion, KMR Group has added nearly 10,000 studies and 200,000 site records to their databases in the past year.

“The increase in KMR Group’s datasets can be attributed to the growing demand the industry has for reliable, detailed, and comparable data. While the rise of publicly available data has certainly made headlines, companies relying on data for decision-making realize that quality counts. We provide a trusted source of trial and site level benchmarks which form the foundation of our recommendations and opportunities that help our clients accelerate drug development,” comments Linda Martin, President and Founder of KMR Group.

For more information about KMR Group’s clinical dataset contact: Lyndsey McKay, Associate Director, Marketing Tel: +1 (312) 795-0400 Email: lmckay [at]

About KMR

KMR Group has worked exclusively in biopharmaceutical R&D since the early 1990s. KMR Group is an industry leader in benchmarking, analytics and performance management as well as a developer of on-line analytics tools that enable access to propriety and rich datasets. KMR's clinical platform contains the most reliable source for trial performance, recruitment and site metrics data, with nearly 30,000 global clinical trials. Clients depend on these tools to benchmark performance, define recruitment strategies and shape enrollment plans and to identify best performing sites.

Visit our website at

Follow us on Twitter @KMRGroupInc

Back to news